The modified vaccinia Ankara-Bavarian Nordic mpox vaccine (MVA-BN; Jynneos) generated robust immune responses in adolescents ...

New data show tolerability and no evidence of spreading to blood or tissues even at high doses of Tonix’s attenuated ...

A NEW strain of the mpox virus has been detected in the UK, and now an expert has warned not to confuse the symptoms with ...

The Department of Microbiology and Immunology is one of 25 departments within the RSOM. It is dedicated to advancing the ...

Q3 2024 Earnings Call Transcript November 7, 2024 Operator: Good afternoon, ladies and gentlemen, and welcome to the SIGA ...

ProBioGen’s AGE1.CR.PIX been developed as a stable proliferating avian cell line that is highly permissive for different ...

Chatham, New Jersey Wednesday, November 6, 2024, 18:00 Hrs [IST] ...

The Company's most advanced product candidate, Olvi-Vec (olvimulogene nanivacirepvec), is a proprietary, modified strain of the vaccinia virus. Olvi-Vec currently is being evaluated in ...

KaliVir is at the forefront of developing novel cancer therapies using its proprietary Vaccinia Enhanced Template (VET™) platform. This platform allows for the expression and systemic delivery ...

About SIGA SIGA is a commercial-stage pharmaceutical company and leader in global health focused on the development of innovative medicines to treat and prevent infectious diseases. With a primary ...

Maxitrol is contraindicated in most viral diseases of the cornea and conjunctiva, including epithelial herpes simplex keratitis (dendritic keratitis), vaccinia, varicella, and also in ...

In Japan, we are actively engaged in discussions with our partner, Japan Biotechno Pharma, and regulators regarding the pending new drug application for TPOXX to treat smallpox, mpox, cowpox, and ...